We are live on
!
Find out more
HAG
HighPoint Advisor Group Portfolio holdings
AUM
$2.84B
1-Year Est. Return
31.94%
This Fund
S&P 500
This Quarter
Est. Return
+16.95%
1 Year Est. Return
+31.94%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$821M
AUM Growth
+$268M
(+49%)
Cap. Flow
+$155M
Cap. Flow
% of AUM
18.9%
Top 10 Holdings %
Top 10 Hldgs %
32.96%
Holding
536
New
147
Increased
262
Reduced
76
Closed
40
Avg Time Held
8.4
quarters
Top 10 Avg Time Held
5.7
quarters
Top 20 Avg Time Held
11.3
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$14.1M |
| 2 |
CME Group
CME
|
+$10.3M |
| 3 |
Tesla
TSLA
|
+$8.97M |
| 4 |
AbbVie
ABBV
|
+$8.36M |
| 5 |
Abbott
ABT
|
+$8.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$12.4M |
| 2 |
Fiserv Inc
FISV
|
+$6.48M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$2.65M |
| 4 |
Moderna
MRNA
|
+$1.34M |
| 5 |
Tiziana Life Sciences
TLSA
|
+$1.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.32% |
| 2 | Healthcare | 14.7% |
| 3 | Consumer Discretionary | 13.39% |
| 4 | Financials | 12.62% |
| 5 | Communication Services | 10.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
426
LyondellBasell Industries
LYB
$19.4B
| $201K | 0.02% |
+2,124
| New | +$173K |
2020 Q4
0 quarters
|
|
427
Wintrust Financial
WTFC
$9.66B
| $201K | 0.02% |
+2,949
| New | +$159K |
2020 Q4
0 quarters
|
|
|
RPAI
428
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $201K | 0.02% |
19,915
-2,000
| -9% | -$14.6K |
2014 Q4
24 quarters
|
|
429
Littelfuse
LFUS
$10.8B
| $200K | 0.02% |
+742
| New | +$164K |
2020 Q4
0 quarters
|
|
430
Neighborhood Intelligence Inc
NXH
$186M
| $198K | 0.02% |
+2,101
| New | +$124K |
2020 Q4
0 quarters
|
|
431
Aemetis
AMTX
$120M
| $197K | 0.02% |
+26,826
| New | +$81.5K |
2020 Q4
0 quarters
|
|
432
Takeda Pharmaceutical
TAK
$59.8B
| $197K | 0.02% |
+11,116
| New | +$195K |
2020 Q4
0 quarters
|
|
433
Viatris
VTRS
$20.3B
| $196K | 0.02% |
+10,599
| New | +$173K |
2020 Q4
0 quarters
|
|
|
ZNGA
434
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $190K | 0.02% |
16,767
-109
| -0.6% | -$981 |
2020 Q2
2 quarters
|
|
435
Jiayin Group
JFIN
$70.1M
| $186K | 0.02% |
45,200
| – | – |
2020 Q2
2 quarters
|
|
|
IPOF
436
DELISTED
Social Capital Hedosophia Holdings Corp. VI
IPOF
| $176K | 0.02% |
+11,250
| New | +$128K |
2020 Q4
0 quarters
|
|
437
Lumen Technologies, Inc. Common Stock
LUMN
$5.45B
| $175K | 0.02% |
13,966
-912
| -6% | -$9K |
2019 Q3
5 quarters
|
|
438
SiriusXM
SIRI
$8.94B
| $168K | 0.02% |
2,776
+827
| +42% | +$50.8K |
2018 Q2
10 quarters
|
|
439
AGNC Investment
AGNC
$10.3B
| $167K | 0.02% |
+10,282
| New | +$152K |
2020 Q4
0 quarters
|
|
440
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $162K | 0.02% |
+17,053
| New | +$74.1K |
2020 Q4
0 quarters
|
|
441
LexinFintech Holdings
LX
$116M
| $148K | 0.02% |
+14,000
| New | +$100K |
2020 Q4
0 quarters
|
|
442
Chimera Investment
CIM
$750M
| $126K | 0.02% |
+3,803
| New | +$110K |
2020 Q4
0 quarters
|
|
443
iBio
IBIO
$56M
| $125K | 0.02% |
+95
| New | +$77.4K |
2020 Q4
0 quarters
|
|
444
DELISTED
Marathon Oil Corporation
MRO
| $124K | 0.02% |
+13,979
| New | +$75.1K |
2020 Q4
0 quarters
|
|
|
PRTK
445
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $122K | 0.01% |
15,279
+110
| +0.7% | +$647 |
2019 Q2
6 quarters
|
|
446
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $115K | 0.01% |
1,049
+147
| +16% | +$20K |
2020 Q1
3 quarters
|
|
|
ACER
447
DELISTED
Acer Therapeutics Inc
ACER
| $113K | 0.01% |
+29,205
| New | +$78.6K |
2020 Q4
0 quarters
|
|
|
OIIM
448
DELISTED
02Micro International
OIIM
| $113K | 0.01% |
+12,700
| New | +$82.4K |
2020 Q4
0 quarters
|
|
449
Lloyds Banking Group
LYG
$77.6B
| $97K | 0.01% |
47,455
-7,468
| -14% | -$12.6K |
2018 Q2
10 quarters
|
|
450
Banco Santander
SAN
$195B
| $87K | 0.01% |
25,074
-7,510
| -23% | -$19K |
2018 Q2
10 quarters
|
|
Similar funds
FMC
ORCP
PCIG
DIG
BDLIB
EMFAT
WGI
RL
HighPoint Advisor Group's Q4 2020 Portfolio in Review
As of Q4 2020, HighPoint Advisor Group held 536 positions worth $821M, up 49% from $553M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
HighPoint Advisor Group deployed $155M of net new capital in Q4 2020, opening 147 new positions and adding to 262 existing holdings. Its largest new stake was CME Group: 60,752 shares worth $11.7M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Clorox, an estimated $12.4M trimmed.
- HighPoint Advisor Group's largest Q4 2020 buy was CME Group: 60,752 shares worth $11.7M.
- HighPoint Advisor Group added most to Apple in Q4 2020, an estimated $14.1M increase.
- HighPoint Advisor Group's biggest Q4 2020 reduction was Clorox, cutting an estimated $12.4M.
- HighPoint Advisor Group fully exited Tiziana Life Sciences in Q4 2020, selling an estimated $1.34M.
- HighPoint Advisor Group's ten largest holdings make up 33% of its $821M portfolio in Q4 2020.
- HighPoint Advisor Group opened 147 new positions and closed 40 in Q4 2020.
- HighPoint Advisor Group's portfolio value rose 49% quarter-over-quarter to $821M.
Based on HighPoint Advisor Group's 13F filing for Q4 2020, filed 10 Feb 2021.